Background Image
Table of Contents Table of Contents
Previous Page  15 / 61 Next Page
Information
Show Menu
Previous Page 15 / 61 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 32, No 4, July/August 2021

AFRICA

187

R

T

S

Q

P

R

T

S

Q

P

R

T

S

Q

P

Long term prophylaxis and management

of Angina Pectoris

1

No first-pass metabolism.

100% bioavalability

2,3

Twice-daily dosing

regimen shown to avoid withdrawal and tolerance

4

References:

1.

Ismo

®

South African SAHPRA aproved package insert.

2.

Ismo 20 Product Monograph(2015)

.

3.

Abshagen,U. 1992. Pharmacokinetics of isosorbide mononitrate. The American Journal of Cradiology,

[online] 70 (17),pp.G61-G66

4.

Thadani U, Maranda CR, Amsterdam E, et al. Lack of Pharmacological Tolerance and Rebound Angina Pectoris during Twice-daily Therapy with isosorbide-5-mononitrate.

Annals of Internal Medicine. 1994.; 120: 353-359.

ISMO

®

-20 R/7.1.4/136. Each Ismo

®

-20 Tablet contains Isosorbide-5-mononitrate 20mg.

S3

For full prescribing information, please refer to the approved package insert

Pharmaco Distribution (Pty) Ltd.

3 Sandown Valley Crescent, South Tower, 1st Floor

Sandton, 2196. PO Box 786522, Sandton, 2146. South Africa

Tel: +27 11 784 0077. Fax: +27 11 784 6994.

www.pharmaco.co.za

ISA_21_01

Trust the Original!

abdominal aortic aneurysm in the Medicare population.

N Engl J Med

2015;

373

(4): 328–338.

12. Bastos RM, Filho AR, Blasbalg R, Caffaro RA, Karakhanian WK,

Rocha AJ. A multidetector tomography protocol for follow-up of endo-

vascular aortic aneurysm repair.

Clinics

2011;

66

(12): 2025–2029.

13. Ay D, Erdolu B, Yumun G,

et al

. The effect of anatomical factors on

mortality rates after endovascular aneurysm repair.

Cardiovasc J Afr

2016;

27

(1): 12–15.

14. Cho JS, Dillavou ED, Rhee RY, Makaroun MS. Late abdominal aortic

aneurysm enlargement after endovascular repair with the Excluder

device.

J Vasc Surg

2004;

39

(6): 1236–1241; discussion 2141–2142.

15. Rand T, Uberoi R, Cil B, Munneke G, Tsetis D. Quality improvement

guidelines for imaging detection and treatment of endoleaks following

endovascular aneurysm repair (EVAR

). Cardiovasc Intervent Radiol

2012;

36

(1): 35–45.

16. Stavropoulos SW, Charagundla SR. Imaging techniques for detection

and management of endoleaks after endovascular aortic aneurysm

repair.

Radiology

2007;

243

(3): 641–655.

17. Rhee SJ, Ohki T, Veith FJ, Kurvers H. Current status of management of

type II endoleaks after endovascular repair of abdominal aortic aneu-

rysms.

Ann Vasc Surg

2003;

17

(3): 335–344.

18. Cao P, De Rango P, Verzini F, Parlani G. Endoleak after endovascular

aortic repair: classification, diagnosis and management following endo-

vascular thoracic and abdominal aortic repair.

J Cardiovasc Surg

2010;

51

(1): 53–69.

19. Broker HS, Foteh KI, Murphy EH,

et al

. Device-specific aneurysm sac

morphology after endovascular aneurysm repair: evaluation of contem-

porary graft materials.

J Vasc Surg

2008;

47

(4): 702–706.

20. Sirignano P, Menna D, Capoccia L,

et al.

Preoperative intrasac throm-

bus load predicts worse outcome after elective endovascular repair

of abdominal aortic aneurysms.

J Vasc Interv Radiol

2015;

26

(10):

1431–1436.

21. Blankensteijn J.D, Prinssen M. Does fresh clot shrink faster than preex-

istent mural thrombus after endovascular AAA repair?

J Endovasc Ther

2002;

9

: 458–463.

22. Çil BE, Canyi

ğ

it M, Çiftçi TT,

et al

. Endovascular treatment of aortic

lesions using the Medtronic

®

Talent system: single center experience with

mid-term follow-up.

Anatol J Cardiol

2008;

8

(2): 134–138.